[{"address1": "1200 Page Mill Road", "city": "Palo Alto", "state": "CA", "zip": "94304", "country": "United States", "phone": "650 281 0850", "website": "https://kodiak.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company's preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), an unconjugated bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.", "fullTimeEmployees": 123, "companyOfficers": [{"maxAge": 1, "name": "Dr. Victor  Perlroth M.D.", "age": 52, "title": "Co-Founder, Chairman, CEO & President", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 1308492, "exercisedValue": 0, "unexercisedValue": 6405456}, {"maxAge": 1, "name": "Mr. John A. Borgeson CPA, M.B.A.", "age": 63, "title": "Executive VP, CFO & Secretary", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 795799, "exercisedValue": 0, "unexercisedValue": 2317602}, {"maxAge": 1, "name": "Dr. Dolly S. Chang M.D., M.P.H., Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Hong  Liang Ph.D.", "age": 53, "title": "Senior Vice President of Development", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 300709, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Raillard Ph.D.", "title": "Senior Vice President of Chemical Development & Manufacturing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Almas  Qudrat M.Sc.", "title": "Chief Quality Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. J. Pablo Velazquez-Martin M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Laurent  Ducay Ph.D.", "title": "Senior VP of Biologics Development & Manufacturing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1767225600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 26.62, "open": 27.04, "dayLow": 26.45, "dayHigh": 27.84, "regularMarketPreviousClose": 26.62, "regularMarketOpen": 27.04, "regularMarketDayLow": 26.45, "regularMarketDayHigh": 27.84, "payoutRatio": 0.0, "beta": 2.672, "forwardPE": -7.1778135, "volume": 621946, "regularMarketVolume": 621946, "averageVolume": 945804, "averageVolume10days": 1064900, "averageDailyVolume10Day": 1064900, "bid": 26.62, "ask": 33.45, "bidSize": 1, "askSize": 2, "marketCap": 1692262400, "fiftyTwoWeekLow": 1.92, "fiftyTwoWeekHigh": 31.18, "allTimeHigh": 171.21, "allTimeLow": 1.37, "fiftyDayAverage": 23.001, "twoHundredDayAverage": 11.13245, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1457322880, "profitMargins": 0.0, "floatShares": 33374182, "sharesOutstanding": 61048428, "sharesShort": 4674452, "sharesShortPriorMonth": 4506500, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0881, "heldPercentInsiders": 0.04777, "heldPercentInstitutions": 0.77755, "shortRatio": 6.51, "shortPercentOfFloat": 0.1424, "impliedSharesOutstanding": 61048429, "bookValue": 0.448, "priceToBook": 61.874996, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -217336000, "trailingEps": -4.12, "forwardEps": -3.8619, "enterpriseToEbitda": -7.119, "52WeekChange": 2.4084506, "SandP52WeekChange": 0.18594909, "quoteType": "EQUITY", "currentPrice": 27.72, "targetHighPrice": 50.0, "targetLowPrice": 2.0, "targetMeanPrice": 27.5, "targetMedianPrice": 29.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 72038000, "totalCashPerShare": 1.361, "ebitda": -204704000, "totalDebt": 62201000, "quickRatio": 1.698, "currentRatio": 1.785, "debtToEquity": 262.54, "returnOnAssets": -0.47210997, "returnOnEquity": -2.07915, "freeCashflow": -41598248, "operatingCashflow": -126700000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "KOD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Kodiak Sciences Inc", "longName": "Kodiak Sciences Inc.", "exchange": "NGM", "messageBoardId": "finmb_321992085", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 4.13223, "regularMarketPrice": 27.72, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1538659800000, "postMarketChangePercent": 0.97402763, "postMarketPrice": 27.99, "postMarketChange": 0.27000046, "regularMarketChange": 1.1, "regularMarketDayRange": "26.45 - 27.84", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 945804, "fiftyTwoWeekLowChange": 25.8, "fiftyTwoWeekLowChangePercent": 13.4375, "fiftyTwoWeekRange": "1.92 - 31.18", "fiftyTwoWeekHighChange": -3.460001, "fiftyTwoWeekHighChangePercent": -0.1109686, "fiftyTwoWeekChangePercent": 240.84506, "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "earningsCallTimestampStart": 1711657800, "earningsCallTimestampEnd": 1711657800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.12, "epsForward": -3.8619, "epsCurrentYear": -4.25677, "priceEpsCurrentYear": -6.5119796, "fiftyDayAverageChange": 4.719, "fiftyDayAverageChangePercent": 0.205165, "twoHundredDayAverageChange": 16.58755, "twoHundredDayAverageChangePercent": 1.4900179, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "marketState": "CLOSED", "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1768004573, "regularMarketTime": 1767992401, "displayName": "Kodiak Sciences", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]